These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 12136254)

  • 41. Initial tumor size predicts histologic response and survival in localized osteosarcoma patients.
    Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Jeon DG
    J Surg Oncol; 2008 Apr; 97(5):456-61. PubMed ID: 18270971
    [TBL] [Abstract][Full Text] [Related]  

  • 42. (99m)Tc-MDP uptake in soft-tissue osteosarcoma in a dog.
    Lass P; Krzemiński M; Teodorczyk J
    Nucl Med Rev Cent East Eur; 2004; 7(2):189. PubMed ID: 15968610
    [No Abstract]   [Full Text] [Related]  

  • 43. [Significance of bone scintigraphy in the observation of the therapeutic effects in metastatic bone cancer].
    Kosuda S; Kondo M; Masaki H; Endo M; Ando Y; Takagi Y; Kubo A; Hashimoto S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1982 May; 42(5):454-66. PubMed ID: 6217442
    [No Abstract]   [Full Text] [Related]  

  • 44. [Analysis of prognostic factors in osteosarcoma adult patients, a single institution experience].
    Adamkova Krakorova D; Vesely K; Zambo I; Tucek S; Tomasek J; Jureckova A; Janicek P; Cerny J; Pazourek L; Ondrusek S; Selingerova I
    Klin Onkol; 2012; 25(5):346-58. PubMed ID: 23102196
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bone scintigraphy in osteosarcoma: a single institution experience.
    Powers JM; Cost C; Cederberg K; Leonard D; Leavey PJ
    J Pediatr Hematol Oncol; 2014 Nov; 36(8):e543-5. PubMed ID: 24942017
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessment of chemotherapy-induced changes in bone sarcomas: clinical experience with 99Tcm-MDP three-phase dynamic bone scintigraphy.
    Ozcan Z; Burak Z; Kumanlioğlu K; Sabah D; Başdemir G; Bilkay B; Cetingül N; Ozkiliç H
    Nucl Med Commun; 1999 Jan; 20(1):41-8. PubMed ID: 9949412
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Unusual presentation of extraosseous metastases on bone scintigraphy.
    Xie W; Padhy AK; Wong WY
    Clin Nucl Med; 2012 Aug; 37(8):793-7. PubMed ID: 22785515
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bone scans in neuroblastoma.
    Bhogate BM; Samuel AM; Ramanathan P
    Indian J Cancer; 1993 Mar; 30(1):5-9. PubMed ID: 8500809
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pulmonary tumor-embolism from intravascular osteosarcoma demonstrated by bone scintigraphy.
    Hoefnagel CA; Marcuse HR; Somers R
    Clin Nucl Med; 1982 Dec; 7(12):574-6. PubMed ID: 6217015
    [No Abstract]   [Full Text] [Related]  

  • 50. Bone scintigraphy in lung cancer: a reappraisal.
    Merrick MV; Merrick JM
    Br J Radiol; 1986 Dec; 59(708):1185-94. PubMed ID: 3801798
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thallium-201 scintigraphy for the assessment of long-term prognosis in patients with osteosarcoma.
    Inaki A; Taki J; Wakabayashi H; Sumiya H; Zen Y; Tsuchiya H; Kinuya S
    Ann Nucl Med; 2012 Aug; 26(7):545-50. PubMed ID: 22610389
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Whole-body bone scintigraphy in the diagnosis and follow-up of the evolution of breast cancer].
    Muşat E; Stefănescu C; Rusu V
    Rev Med Chir Soc Med Nat Iasi; 1999; 103(1-2):163-9. PubMed ID: 10756905
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Bone scintigraphy in assessing the success of chemotherapy in osteosarcoma].
    Knop J; Stritzke P; Montz R; Delling G; Winkler K
    Nuklearmedizin; 1985 Apr; 24(2):75-81. PubMed ID: 2410864
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Combined bone marrow and skeletal scintigraphy in osseous and myelogenous diseases].
    Hotze A; Löw A; Mahlstedt J; Wolf F
    Rofo; 1984 Jun; 140(6):717-23. PubMed ID: 6234628
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Radiological work-up of primary malignant bone tumours.
    Taconis WK; van der Eyken JW
    Diagn Imaging Clin Med; 1985; 54(1):28-38. PubMed ID: 3855725
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Value of combined technetium-99m hydroxy methylene diphosphonate and thallium-201 imaging in detecting bone metastases from thyroid carcinoma.
    Alam MS; Takeuchi R; Kasagi K; Misaki T; Miyamoto S; Iida Y; Hidaka A; Konishi J
    Thyroid; 1997 Oct; 7(5):705-12. PubMed ID: 9349573
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Scintigraphy in the diagnosis and follow-up of bone neoplasms in childhood].
    Silvestro L; Testa A; Mussa GC
    Minerva Pediatr; 1987 May; 39(10):463-70. PubMed ID: 2821371
    [No Abstract]   [Full Text] [Related]  

  • 58. The cause and clinical significance of central tumor photopenia on thallium scintigraphy of pediatric osteosarcoma of the extremity.
    McCarville MB; Barton EH; Cameron JR; Xiong X; Daw NC; Kaste SC; Wu S; Glass JO; Reddick WE
    AJR Am J Roentgenol; 2007 Feb; 188(2):572-8. PubMed ID: 17242270
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Technetium-99m MDP scintigraphy. An insensitive tool for the detection of bone marrow metastases.
    Gulenchyn KY; Papoff W
    Clin Nucl Med; 1987 Jan; 12(1):45-6. PubMed ID: 3815996
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictors of a positive baseline bone scan in breast cancer.
    Ho YY; Chan YH
    Australas Radiol; 2005 Feb; 49(1):21-6. PubMed ID: 15727605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.